Roland Werner Burli

Title: The Innovations of Roland Werner Burli

Introduction

Roland Werner Burli is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors involved in various medical conditions. With a total of two patents to his name, Burli's work is recognized for its potential impact on pain management and inflammatory disorders.

Latest Patents

Burli's latest patents focus on inhibitors of protease-activated receptor-2. The first patent relates to certain substituted imidazole compounds, pharmaceutical compositions containing them, and methods of using them for treating pain, musculoskeletal inflammation, neuroinflammatory disorders, airway inflammation, itch, dermatitis, colitis, and related conditions. The second patent also addresses inhibitors of protease-activated receptor-2, detailing substituted imidazole and triazole compounds with similar therapeutic applications. The compounds are defined by a specific formula where X is N or CH, Z and Y are N or C (but both not N), and R-R are as defined in the patent.

Career Highlights

Burli is currently associated with Heptares Therapeutics Limited, where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong focus on developing new therapeutic options for challenging medical conditions.

Collaborations

Some of Burli's notable coworkers include John Graham Cumming and Frank Xinhe Wu, who contribute to the collaborative environment at Heptares Therapeutics Limited.

Conclusion

Roland Werner Burli's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in treatment options for various inflammatory and pain-related conditions.